Answers are grounded in this paper and cite their sources.
Systemic corticosteroid use in acute respiratory failure has yielded uncertain benefits, partially because of off-target side effects. Inhaled corticosteroids (ICSs) confer localized antiinflammatory benefits and may protect adults with direct lung injury (DLI) from developing respiratory failure. To our knowledge, this relationship has not been studied in children.
No takes yet. Share an insight, caveat, or question.
Landzberg et al. (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: